Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

NOD2 mutations are associated with the development of intestinal failure in the absence of Crohn's disease.

Schäffler H, Schneider N, Hsieh CJ, Reiner J, Nadalin S, Witte M, Königsrainer A, Blumenstock G, Lamprecht G.

Clin Nutr. 2013 Dec;32(6):1029-35. doi: 10.1016/j.clnu.2013.02.014. Epub 2013 Mar 7.

PMID:
23562557
2.

Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.

Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S.

Am J Gastroenterol. 2009 Jul;104(7):1723-33. doi: 10.1038/ajg.2009.184. Epub 2009 May 19.

PMID:
19455129
3.

NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship.

Cukovic-Cavka S, Vermeire S, Hrstic I, Claessens G, Kolacek S, Jakic-Razumovic J, Krznaric Z, Grubelic K, Radic D, Misak Z, Jadresin O, Rutgeerts P, Vucelic B.

Eur J Gastroenterol Hepatol. 2006 Aug;18(8):895-9.

PMID:
16825909
4.

NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.

Karban A, Waterman M, Panhuysen CI, Pollak RD, Nesher S, Datta L, Weiss B, Suissa A, Shamir R, Brant SR, Eliakim R.

Am J Gastroenterol. 2004 Jun;99(6):1134-40.

PMID:
15180737
5.

Nucleotide oligomerization domain 2 polymorphisms in patients with intestinal failure.

Guerra JF, Zasloff M, Lough D, Abdo J, Hawksworth J, Mastumoto C, Girlanda R, Island E, Shetty K, Kaufman S, Fishbein T.

J Gastroenterol Hepatol. 2013 Feb;28(2):309-13. doi: 10.1111/jgh.12037.

PMID:
23173613
6.

Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.

Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, Pfennig S, Jürgens M, Schmechel S, Konrad A, Göke B, Ochsenkühn T, Müller-Myhsok B, Lohse P, Brand S.

Inflamm Bowel Dis. 2008 Apr;14(4):437-45.

PMID:
18088064
7.

[NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].

Lakatos L, Lakatos PL, Willheim-Polli C, Reinisch W, Ferenci P, Tulassay Z, Molnár T, Kovács A, Papp J, Szalay F; Hungarian IBD Study Group.

Orv Hetil. 2004 Jul 4;145(27):1403-11. Hungarian.

PMID:
15320482
8.

Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.

Cleynen I, González JR, Figueroa C, Franke A, McGovern D, Bortlík M, Crusius BJ, Vecchi M, Artieda M, Szczypiorska M, Bethge J, Arteta D, Ayala E, Danese S, van Hogezand RA, Panés J, Peña SA, Lukas M, Jewell DP, Schreiber S, Vermeire S, Sans M.

Gut. 2013 Nov;62(11):1556-65. doi: 10.1136/gutjnl-2011-300777. Epub 2012 Dec 21.

PMID:
23263249
9.

The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.

Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Török HP, Tonenchi L, Pfennig S, Haller D, Griga T, Klein W, Epplen JT, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Mussack T, Folwaczny M, Müller-Myhsok B, Brand S.

Am J Gastroenterol. 2008 Mar;103(3):682-91. Epub 2007 Dec 20.

PMID:
18162085
10.

NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype- phenotype analysis.

Heresbach D, Gicquel-Douabin V, Birebent B, D'halluin PN, Heresbach-Le Berre N, Dreano S, Siproudhis L, Dabadie A, Gosselin M, Mosser J, Semana G, Bretagne JF, Yaouanq J.

Eur J Gastroenterol Hepatol. 2004 Jan;16(1):55-62.

PMID:
15095853
11.

Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.

Bianchi V, Maconi G, Ardizzone S, Colombo E, Ferrara E, Russo A, Tenchini ML, Porro GB.

Eur J Gastroenterol Hepatol. 2007 Mar;19(3):217-23.

PMID:
17301648
12.

Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease.

Abreu MT, Taylor KD, Lin YC, Hang T, Gaiennie J, Landers CJ, Vasiliauskas EA, Kam LY, Rojany M, Papadakis KA, Rotter JI, Targan SR, Yang H.

Gastroenterology. 2002 Sep;123(3):679-88.

PMID:
12198692
13.

Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population.

Hume GE, Fowler EV, Doecke J, Simms LA, Huang N, Palmieri O, Griffiths LR, Florin TH, Annese V, Radford-Smith GL.

Inflamm Bowel Dis. 2008 May;14(5):585-90. doi: 10.1002/ibd.20362.

PMID:
18213697
14.

Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility.

Levine A, Kugathasan S, Annese V, Biank V, Leshinsky-Silver E, Davidovich O, Kimmel G, Shamir R, Palmieri O, Karban A, Broeckel U, Cucchiara S.

Inflamm Bowel Dis. 2007 Dec;13(12):1509-15. Erratum in: Inflamm Bowel Dis. 2008 Dec;14(12):1760. Orazio, Palmieri [corrected to Palmieri, Orazio].

PMID:
17763471
15.

CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease.

Heliö T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, Färkkilä M, Krusius T, Kontula K.

Gut. 2003 Apr;52(4):558-62.

16.

The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants.

Glas J, Seiderer J, Tillack C, Pfennig S, Beigel F, Jürgens M, Olszak T, Laubender RP, Weidinger M, Müller-Myhsok B, Göke B, Ochsenkühn T, Lohse P, Diegelmann J, Czamara D, Brand S.

PLoS One. 2010 Dec 30;5(12):e14466. doi: 10.1371/journal.pone.0014466.

17.

The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis.

Adler J, Rangwalla SC, Dwamena BA, Higgins PD.

Am J Gastroenterol. 2011 Apr;106(4):699-712. doi: 10.1038/ajg.2011.19. Epub 2011 Feb 22. Review.

PMID:
21343918
18.

The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.

Schnitzler F, Friedrich M, Wolf C, Angelberger M, Diegelmann J, Olszak T, Beigel F, Tillack C, Stallhofer J, Göke B, Glas J, Lohse P, Brand S.

PLoS One. 2014 Nov 3;9(11):e108503. doi: 10.1371/journal.pone.0108503. eCollection 2014.

19.

Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation.

Büning C, Genschel J, Bühner S, Krüger S, Kling K, Dignass A, Baier P, Bochow B, Ockenga J, Schmidt HH, Lochs H.

Aliment Pharmacol Ther. 2004 May 15;19(10):1073-8.

20.

NOD2 gene mutations associate weakly with ulcerative colitis but not with Crohn's disease in Indian patients with inflammatory bowel disease.

Pugazhendhi S, Santhanam S, Venkataraman J, Creveaux I, Ramakrishna BS.

Gene. 2013 Jan 10;512(2):309-13. doi: 10.1016/j.gene.2012.10.015. Epub 2012 Oct 23.

PMID:
23085276

Supplemental Content

Support Center